Research published in obesity journals shows that GLP-1 receptor activity returns to baseline within approximately one week, meaning hunger signals and cravings resurface almost immediately
However, the small sample-size, the short treatment period, the absence of control groups, the lack of liver biopsy evaluation after treatment are just some of the limitations of these studies
Whether someone is switching treatments or completely new to GLP-1s, confidence comes from education
In non-diabetics, were talking about semaglutide at higher weekly doses
Effects on cortisol and prolactin are more commonly discussed with ghrelin-mimetic secretagogues than with pure GHRH analogs, but any manipulation of the neuroendocrine axis can have downstream effects
[DOI] [PMC free article] [PubMed] [Google Scholar] 11.Zheng T.P., Liu Y.H., Yang L.X., Qin S.H., Liu H.B